Related Experiment Video
Updated: Aug 1, 2026
04:39
Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Subclinical hyperthyroidism in patients with nodular goiter represents a hypermetabolic state
1Section of Endocrinology, Department of Internal Medicine, Esbjerg County Hospital, Esbjerg, Denmark. jkv@ribeamt.dk
Summary
Subclinical hyperthyroidism (sH) patients exhibit a hypermetabolic state, indicated by increased oxygen consumption and lower bone density. These metabolic changes normalize when thyroid hormone levels are reduced, suggesting altered cellular sensitivity.
Area of Science:
- Endocrinology
- Metabolic research
- Thyroid disorders
Background:
- Subclinical hyperthyroidism (sH) is characterized by suppressed TSH with normal free T4 and T3 levels.
- The metabolic implications of sH remain incompletely understood.
- Patients with nodular goiter are often screened for thyroid dysfunction.
Purpose of the Study:
- To investigate the metabolic status in patients with subclinical hyperthyroidism.
- To assess basal oxygen consumption (VO2), bone mineral density (BMD), and circadian TSH variation in sH.
- To examine the pituitary-thyroid axis response to thyroid hormone reduction.
Main Methods:
- Included 13 patients with sH and 13 controls with nodular goiter.
- Measured basal oxygen consumption (VO2).
- Assessed bone mineral density (BMD) and circadian TSH variation.
- Administered methimazole to lower thyroid hormone levels.
Main Results:
- Patients with sH showed abolished circadian TSH variation (loss of night surge).
- Basal VO2 was significantly higher in sH patients compared to controls.
- BMD was significantly lower in sH patients.
- Methimazole treatment normalized VO2 and restored circadian TSH variation.
Conclusions:
- Suppressed TSH with normal peripheral thyroid hormones in sH is associated with a hypermetabolic state.
- Findings suggest altered cellular sensitivity to thyroid hormones or a shifted cellular set point.
- The pituitary-thyroid axis remains responsive, as evidenced by normalization upon hormone reduction.
Related Concept Videos
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...